Condition 1: Deep Vein Thrombosis. Condition 2: Pulmonary Embolism. Phlebitis and thrombophlebitis of other deep vessels of lower extremities Deep vein thrombosis Pulmonary embolism
Conditions
Interventions
Intervention 1: Intervention group: People who receive oral Rivaroxaban 10mg Daily for 12 Days then at the same time, distilled water were injected to those. Intervention 2: Control group: People who
Sponsors
Sabzevar University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to No maximum
Inclusion criteria
Inclusion criteria: All People over the Age of 20 Years who are Candidates for Anticoagulant Therapy
Exclusion criteria
Exclusion criteria: History of Hypersensitivity Reaction to either of the Two Drugs Severe Bleeding Pregnancy and Lactation History of Recent Labor or any Recent Injury Having Liver Disease or any other Disease that Leads to an Increased Risk of Bleeding.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Deep Vein Thrombosis. Timepoint: One Month after Receiving Treatment. Method of measurement: Examinations and Color Doppler Ultrasound.;Pulmonary Embolism. Timepoint: One Month after Receiving Treatment. Method of measurement: Examinations and Color Doppler Ultrasound. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactsalar abdi
Sabzevar University of Medical Sciences
Outcome results
None listed